Fierce v. Kijakazi

CourtDistrict Court, N.D. California
DecidedSeptember 30, 2025
Docket3:23-cv-05258
StatusUnknown

This text of Fierce v. Kijakazi (Fierce v. Kijakazi) is published on Counsel Stack Legal Research, covering District Court, N.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Fierce v. Kijakazi, (N.D. Cal. 2025).

Opinion

1 2 3 4 UNITED STATES DISTRICT COURT 5 NORTHERN DISTRICT OF CALIFORNIA 6 7 SEAN F.,1 Case No. 23-cv-05258-AMO

8 Plaintiff, ORDER GRANTING REVERSAL OF 9 v. SOCIAL SECURITY COMMISSIONER’S FINAL DECISION 10 KILOLO KIJAKAZI, et al., AND DENYING REQUEST FOR AFFIRMANCE OF DENIAL OF 11 Defendants. SOCIAL SECURITY BENEFITS

12 Re: Dkt. Nos. 11, 12

13 Plaintiff Sean F. seeks reversal of the Social Security Administration Commissioner’s final 14 administrative decision denying his application for benefits under Title XVI of the Social Security 15 Act and remand of this case in accordance with 42 U.S.C. § 405(g). The Commissioner asks that 16 the Court affirm the decision. For the reasons stated below, the Court GRANTS Plaintiff’s 17 request to reverse the Commissioner’s unfavorable decision and DENIES the Commissioner’s 18 request to affirm the denial of benefits, and remands for further proceedings consistent with this 19 order. 20 I. BACKGROUND 21 On February 21, 2020, Plaintiff protectively filed applications2 for Social Security 22

23 1 The Court partially redacts Plaintiff’s name to mitigate privacy concerns. See Heather L. v. Saul, No. 19-CV-02483-SI, 2020 WL 3504468, at *1 n.1 (N.D. Cal. June 29, 2020) (citing Fed. R. Civ. 24 P. 5.2(c)(2)(B)).

25 2 “Protective filing is a Social Security term for the first time [a claimant] contact[s] the Social Security Administration to file a claim for disability or retirement. Protective filing dates may 26 allow an individual to have an earlier application date than the actual signed application date. This is important because protective filing often affects the entitlement date for disability and 27 retirement beneficiaries along with their dependents.” Burnham v. Berryhill, No. 17-CV-05476- 1 Disability Insurance (“SSDI”) benefits under Title II of the Social Security Act and for 2 Supplemental Security Income (“SSI”) under Title XVI of the Act. Administrative Record (“AR”) 3 (Dkt. No. 10) at 20. In support of the applications, Plaintiff submitted a disability report3 and a 4 third-party function report.4 Id. at 338-340, 350-357, 369-371, 387-393. 5 In the disability report, Plaintiff identified the following conditions as limiting his ability to 6 work: bone infection, blood clots in brain, mild nonproliferation diabetic retinopathy of both eyes, 7 diabetes mellitus type 2, cranial nerve disorder, fear of social situations. Id. at 343.5 He indicated 8 that he has not developed any new physical or mental conditions between his February 2020 report 9 and his May 2021 report, but indicated that in approximately January 2021 he experienced 10 “changes/decrease in vision due to diabetes and prior [brain] clot.” See id. at 373. In his list of 11 medications, Plaintiff indicated that as of May 2021, he was taking Insulin and Metformin for 12 diabetes and Kolonopin and Zoloft for anxiety/panic disorder. Id. at 375-376. 13 In the third-party function report, Plaintiff’s father described how Plaintiff’s illnesses, 14 injuries, or conditions limited his ability to work as follows: “He is afraid of going outside. He 15 has very poor vision due to blood clots. His hand is swollen + he can’t grip or close hand fully.” 16 Id. at 379. Plaintiff’s father indicated Plaintiff’s illnesses, injuries, and conditions affected his 17 ability to lift, hear, see, remember, concentrate, and use his hands, as he “can lift about 3 lbs with 18 his right hand” but “can’t grip,” and has “impaired vision from blood clots and diabetes.” Id. at 19 384. Plaintiff’s father notes Plaintiff’s ability to follow written instructions is fair, his ability to 20 21 3 The Administration uses the information a claimant provides in a disability report to decide 22 whether the claimant is disabled. See Form SSA-3368-BK, Soc. Sec. Admin. Forms, available at https://www.ssa.gov/forms/ssa-3368-bk.pdf (last visited Sept. 30, 2025). 23

24 4 A function report, whether from the claimant or from a third-party who knows the claimant, is a form the Administration uses to obtain information about the claimant’s activities and 25 abilities. See Form SSA-3373-BK, Soc. Sec. Admin. Forms, available at https://www.ssa.gov/forms/ssa-3373-bk.pdf (last visited Sept. 30, 2025); see also Form SSA- 26 3380-BK, Soc. Sec. Admin. Forms, available at https://www.ssa.gov/forms/ssa-3380.pdf (last visited Sept. 25, 2025). 27 1 follow spoken instructions is good, and his ability to get along with authority figures is very good. 2 Id. at 384-385. Before Plaintiff’s illness, Plaintiff’s father indicates Plaintiff was “able to work, 3 grip, lift, see normally,” “go outside + socialize with other people, [and] drive,” and “was always 4 outside doing different things.” Id. at 380, 384. Plaintiff’s father indicates he now has a social 5 phobia and is “paranoid to go outside” and “panics when outside the condo” where he lives with 6 his mother and father. Id. at 382. Plaintiff “has to be told to bathe.” Id. at 380-381. 7 Plaintiff’s conditions began in October 2018, when he was hospitalized for approximately 8 two months to be treated for methicillin-resistant staphylococcus aureus bacteremia, optic nerve 9 palsy, and diabetic ketoacidosis, resulting in septic sinus thrombosis and skull-base osteomyelitis.6 10 Id. at 481, 483, 485. Plaintiff is legally blind in his left eye and suffers from diabetic retinopathy 11 in his right eye. Id. at 441. In March 2020, Plaintiff was seen by ophthalmologist Dr. Jong Goel 12 Park for blurry vision in his right eye and cranial nerve palsies in his left eye. Id. at 485. Dr. Park 13 observed that the swelling Plaintiff had experienced since September 2019 was somewhat 14 reduced. Id. at 486. However, Dr. Park noted that despite two Eylea injections in his right eye in 15 the previous four months, Plaintiff’s vision had not improved. Id. at 485. Plaintiff had a cataract 16 in his right eye, but Dr. Park did not recommend surgery until the diabetic macular edema present 17 in that eye was stable for a minimum of three months. Id. at 586. In July 2020, ophthalmologist 18 Dr. Quan Dong Nguyen noted there remained a “suboptimal response” and identified the need to 19 “consider other therapeutic options.” Id. at 600. Plaintiff reported “deteriorating vision” in 20 September 2020. Id. at 588. In February 2021, Dr. James Cohn performed an eye evaluation on 21 Plaintiff on behalf of the Social Security Administration. Id. at 1881-1884. Dr. Cohn provided 22 raw data and handwritten abbreviated notations, and did not provide a narrative report or 23 functional limitations. See id. 24 In March 2021, Plaintiff reported at an appointment that his vision was “a little worse in 25 both eyes for the past few months.” Id. at 1888. In June 2021 and August 2021, Plaintiff received 26 additional injections in his right eye, and reported “[n]o significant vision improvement” in 27 1 August and September 2021, but slight improvement in November 2021. Id. at 1951-1952. In 2 November 2021, Dr. Nguyen again advised to postpone a cataract evaluation as the edema was 3 still present. Id. at 1953. In February 2022, Dr. Nguyen noted Plaintiff reported his vision was 4 “stable in both eyes” and he had “not noticed any improvement or any worsening” since his 5 previous visit in December 2021. Id. at 2076. Dr. Nguyen further noted that Plaintiff “[e]ndorses 6 glare with bright lights and feels temporarily blinded in bright sunlight,” and that he “does not 7 drive due to his vision.” Id. Cataract evaluation and treatment continued to be postponed as the 8 edema remained present, and Dr. Nguyen recommended that if the edema did not improve 9 substantially by Plaintiff’s next visit, he would consider an alternative treatment – intravenous 10 interleukin-6 inhibitor – in “an effort to control the significant diabetic macular edema for the 11 patient.” Id.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
Fierce v. Kijakazi, Counsel Stack Legal Research, https://law.counselstack.com/opinion/fierce-v-kijakazi-cand-2025.